The 2027 Lamborghini Temerario has received a series of software updates designed to sharpen its character without altering its exterior or interior layout. Paolo Rachetti, product line director for the Temerario, confirmed
More
Digital bank Monzo is in early discussions with Brazilian fintech powerhouse Nubank over a potential acquisition that could reach a valuation of between £8bn and £10bn. The UK fintech has been approached
More
Treasury yields surged sharply on Wednesday, raising alarm about the broader impact on consumers, borrowing costs, and overall economic momentum across the United States. Rates along the curve hit levels not seen
More
Chancellor John Healey and Prime Minister Andy Burnham could raise £26bn through sweeping reforms to capital gains taxes and national insurance contributions, according to a new academic proposal. Researchers at the Centre
More
President Donald Trump has announced plans to divide some childhood immunisations into five separate shots, administered as “20% doses” every six months. Trump made the announcement at an Oval Office event, suggesting
More
Accenture (ACN) is among a handful of stocks drawing significant investor attention as markets prepare to open for the new trading week. Abivax (ABVX), the French biopharmaceutical company, is also on the
More
The FTSE 100 is poised to make gains on Monday morning, according to futures data from investment platform IG, reversing some of Friday’s sharp declines. The blue-chip index closed 1.5 per cent
More
A federal court has declined to force Google to sell its ad exchange or open-source its auction logic in a landmark US antitrust ruling. Judge Leonie Brinkema of the Eastern District of
More
Teva Pharmaceutical Industries (TEVA) has begun trading its ordinary shares directly on the New York Stock Exchange, marking a significant milestone for the global drugmaker. The move represents a key step in
More
AbbVie has announced positive topline results from its Phase 3 LUNA study evaluating atogepant for the preventive treatment of menstrual migraine in adults. Atogepant, sold as Qulipta in the US and Aquipta
More